SG Americas Securities
AMAG

SG Americas Securities’s AMAG Pharmaceuticals AMAG Stock Holding History

SG Americas Securities’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,745
Closed -$82K – 3793
2020
Q2 		$82K Buy
+10,745
New +$82.2K ﹤0.01% 3441
2019
Q4 		– Sell
-13,582
Closed -$157K – 3517
2019
Q3 		$157K Buy
+13,582
New +$143K ﹤0.01% 2484
2017
Q3 		– Sell
-17,320
Closed -$319K – 3824
2017
Q2 		$319K Buy
17,320
+7,309
+73% +$145K ﹤0.01% 2134
2017
Q1 		$226K Sell
10,011
-7,286
-42% -$174K ﹤0.01% 2356
2016
Q4 		$602K Buy
17,297
+9,695
+128% +$290K 0.01% 1590
2016
Q3 		$186K Sell
7,602
-2,098
-22% -$52.4K ﹤0.01% 2559
2016
Q2 		$232K Sell
9,700
-1,320
-12% -$30.3K ﹤0.01% 2054
2016
Q1 		$258K Sell
11,020
-125
-1% -$2.97K ﹤0.01% 2054
2015
Q4 		$336K Buy
11,145
+6,198
+125% +$200K ﹤0.01% 1851
2015
Q3 		$197K Sell
4,947
-5,085
-51% -$316K ﹤0.01% 1475
2015
Q2 		$693K Sell
10,032
-1,923
-16% -$121K ﹤0.01% 1265
2015
Q1 		$653K Buy
11,955
+6,948
+139% +$331K ﹤0.01% 1329
2014
Q4 		$213K Buy
+5,007
New +$181K ﹤0.01% 2372
2014
Q2 		– Sell
-6,855
Closed -$133K – 2776
2014
Q1 		$133K Buy
+6,855
New +$146K ﹤0.01% 2105
2013
Q4 		– Sell
-5,969
Closed -$128K – 3148
2013
Q3 		$128K Buy
+5,969
New +$141K ﹤0.01% 2504

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SG Americas Securities's AMAG Position: Q3 2020 in Review

SG Americas Securities sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 10,745 shares — an estimated $82K sold.

SG Americas Securities first reported a position in AMAG in Q3 2013 and held it in 15 quarters. The position peaked at $693K in Q2 2015. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

  • SG Americas Securities reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 10,745 AMAG Pharmaceuticals shares in Q3 2020, an estimated $82K.
  • SG Americas Securities first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 15 quarters.
  • SG Americas Securities's AMAG Pharmaceuticals position peaked at $693K in Q2 2015.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.